Physician profile
Anna E Stern
NPI 1184728834
$5,061.35
in general payments reported to CMS, 2019-2025
47 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,135 · 2020: $1,010 · 2021: $811 · 2022: $670 · 2023: $950 · 2024: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $859.65 | 2019-2024 | Prolia, Evenity, Otezla |
| Abbvie INC. | $367.22 | 2019-2024 | Linzess, Qulipta |
| Glaxosmithkline, LLC. | $363.03 | 2020-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Teva Pharmaceuticals USA, INC. | $315.52 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $285.06 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $264.81 | 2019-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $233.03 | 2019-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $160.42 | 2019-2021 | |
| Lilly USA, LLC | $156.15 | 2019-2023 | Reyvow, Emgality |
| Exact Sciences Corporation | $131.00 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $126.45 | 2023 | |
| Genzyme Corporation | $121.84 | 2024 | |
| Sanofi-Aventis U.S. LLC | $121.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $113.99 | 2019 | |
| Radius Health, INC. | $112.78 | 2020-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.